Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing belladonna alkaloid and phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Allergy to belladonna alkaloid |
Causative agent (attribute) |
False |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
|
Allergy to belladonna alkaloid |
Causative agent (attribute) |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
|
Product containing belladonna alkaloids and ergotamine tartrate and phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
|
Product containing belladonna alkaloid and opium alkaloid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
1 |
Product containing belladonna alkaloid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
1 |
Product containing belladonna alkaloid in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
1 |
Product containing aluminium hydroxide and belladonna alkaloid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Magnesium trisilicate+belladonna 0.15mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
|
Product containing belladonna alkaloid and magnesium trisilicate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Product containing belladonna alkaloid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
1 |
Belladonna alkaloid 16.2 mg and opium 30 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
|
Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
|
Product containing belladonna alkaloid and secbutabarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Belladonna alkaloid- and secbutabarbital-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Product containing belladonna alkaloid and ergotamine and phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Product containing belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Belladonna alkaloid 15 mg and secbutabarbital sodium 15 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
1 |
Belladonna alkaloid 15 mg and secbutabarbital sodium 15 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
1 |
Levorotatory alkaloids of belladonna |
Is a |
False |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
|
Product containing only aluminium hydroxide and belladonna alkaloid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Product containing only belladonna alkaloid and ergotamine and phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Belladonna alkaloid and magnesium trisilicate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Belladonna alkaloid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
1 |
Product containing only belladonna alkaloid and opium alkaloid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
1 |
Belladonna alkaloid and phenobarbital only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Belladonna alkaloid and secbutabarbital only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Product containing only belladonna alkaloid in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
1 |
Product containing only belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Belladonna alkaloid and secbutabarbital only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Belladonna alkaloid only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
1 |
Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Belladonna alkaloid- and opium-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Belladonna alkaloid 16.2 mg and opium 30 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Belladonna alkaloid 16.2 mg and opium 30 mg rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Belladonna alkaloid and opium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Belladonna alkaloid and opium only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Product containing belladonna alkaloid and opium in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
2 |
Belladonna alkaloids adverse reaction |
Causative agent (attribute) |
True |
Belladonna alkaloid (substance) |
Inferred relationship |
Some |
1 |